Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Harmony Biosciences Holdings
Harmony Biosciences Holdings
(HRMY)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Wakix
Pitolisant
2019-08-14
2026-2030
Obstructive sleep apnea
,
Narcolepsy
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Pitolisant
myotonic dystrophy
,
disorders of excessive somnolence
,
sleepiness
,
prader-willi syndrome
,
idiopathic hypersomnia
,
syndrome
,
restless legs syndrome
,
psychomotor agitation
,
narcolepsy
,
cataplexy
,
pregnancy rate
Losartan
drug interactions
Sodium oxybate
pregnancy rate
,
narcolepsy
Aspartame
healthy volunteers/patients
,
alzheimer disease
,
female genital neoplasms
,
melanoma
,
hepatitis b
,
chronic hepatitis b
,
depression
,
major depressive disorder
,
depressive disorder
,
lung neoplasms
,
triple negative breast neoplasms
,
pancreatic neoplasms
,
neoplasm metastasis
,
coronary disease
,
coronary artery disease
,
myocardial ischemia
,
heart diseases
,
chronic hepatitis
,
sickle cell anemia
,
adenocarcinoma
,
sarcoma
,
glioma
,
neuroblastoma
,
precursor cell lymphoblastic leukemia-lymphoma
,
parkinson disease
,
autistic disorder
,
autism spectrum disorder
,
pervasive child development disorders
,
rectal neoplasms
,
covid-19
,
pneumonia
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
,
exanthema
,
nasopharyngeal carcinoma
,
nasopharyngeal neoplasms
,
stomach neoplasms
,
esophageal neoplasms
,
neoplasms
,
colorectal neoplasms
,
human influenza
,
non-small-cell lung carcinoma
,
breast neoplasms
,
lupus nephritis
,
nephritis
,
large b-cell lymphoma diffuse
,
anemia
,
leukemia
,
b-cell lymphoma
,
carcinoma
,
non-hodgkin lymphoma
,
myeloid leukemia acute
,
multiple sclerosis
,
sclerosis
,
hepatocellular carcinoma
,
colonic neoplasms
,
thrombocytopenic purpura idiopathic
,
thrombocytopenic purpura
,
purpura
,
liver cirrhosis
,
neuromyelitis optica
,
kidney diseases
,
membranous glomerulonephritis
,
chronic progressive multiple sclerosis
,
myeloid leukemia
,
nephrotic syndrome
,
nephrosis
,
lipoid nephrosis
,
recurrence
,
ovarian neoplasms
,
hemolysis
,
hemolytic anemia autoimmune
,
hemolytic anemia
,
hepatitis
,
hepatitis a
,
arthritis
,
hepatitis c
,
chronic hepatitis c
,
lymphoma
,
rheumatoid arthritis
,
juvenile arthritis
,
follicular lymphoma
,
syndrome
,
hiv infections
,
asthma
,
heart failure
,
myelodysplastic syndromes
,
preleukemia
,
acquired immunodeficiency syndrome
,
kidney transplantation
,
drug-related side effects and adverse reactions
,
heart disease risk factors
,
cognitive dysfunction
Clemizole
myoclonic epilepsies
,
syndrome
,
lennox gastaut syndrome
Zyn002
drug interactions
Gluconorm
drug interactions
Wellbutrin
type 2 diabetes mellitus
,
hiv infections
,
seasonal affective disorder
,
bipolar disorder
,
psychological sexual dysfunctions
,
crohn disease
,
epilepsy
,
lethargy
,
hyperkinesis
,
attention deficit disorder with hyperactivity
,
mood disorders
,
depressive disorder
,
major depressive disorder
,
depression
,
smoking cessation
,
mental disorders
,
problem behavior
,
chronic obstructive pulmonary disease
,
obstructive lung diseases
,
breast neoplasms
,
dysthymic disorder
,
tobacco use disorder
,
cardiovascular diseases
,
myocardial infarction
,
unstable angina
,
infarction
,
smoking
,
congenital abnormalities
,
pregnancy
,
neoplasms
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use